You are here: Industry Insights > Appointment

News List

Lonza Endotoxin Expert Appointed Chair of ASMFC Horseshoe Crab Panel contractpharma
November 15, 2018
Burgenson elected to position in recognition of more than 35 years of experience in the biomedical use of horseshoe crabs
OncoSec Appoints Chief Clinical Development Officer expressbpd
October 30, 2018
The award was given in recognition of the exemplary contributions to the profession and improvement of society in line with the mission of FAPA in Asia
Achillion appoints new CMO biospectrumasia
August 22, 2018
Achillion also expanded its clinical development group with the recent appointments of Laura Barrow, Pharm.D. as VP, Clinical Operations and Head of Project Management, and Marc Uknis, M.D. as VP of Clinical Development, Head of Nephrology Therapeutics.
Dr R Ananthanarayanan appointed as Cipla’s global COO financialexpress
August 16, 2018
He will oversee R&D, manufacturing, supply chain, the API business and the key geographies of North America, Europe and Emerging Markets
AXM Pharma appoints new biospectrumasia
July 05, 2018
AXM Pharma is pleased to announce that its Chairman, Mr. Emmanuel Neossi, has appointed Linda L. Forster as the new Chief Executive Officer effective immediately.
Algenuity appoints new Chief Scientific Officer europeanpharmaceuticalreview
May 22, 2018
Algenuity, a leader in algal biology and industrial biotechnology, is delighted to welcome Dr Alex Pudney to the team as Chief Scientific Officer…
Semma Therapeutics appoints new President biospectrumasia
May 15, 2018
Dr. Sanna will succeed Elizabeth Stoner who has been serving as the Interim CEO and will remain as an advisor to the Company
Immunomedics appoints new CMO biospectrumasia
April 11, 2018
Dr. Iannone brings more than thirteen years of experience in clinical drug development, including the approval of several targeted and immuno-oncology medicines at AstraZeneca/MedImmune and Merck & Co.
Amneal Pharmaceuticals welcomes new President Robert Stewart pharmaasia
December 29, 2017
Prior to becoming Allergan COO in 2016, Stewart served various roles after joining the company in 2009 as Senior Vice President, Global Operations.
Jim Loerop appointed as Chief Corporate Development Officer of Lupin biospectrumasia
September 20, 2017
Prior to Alexion, he held multiple leadership positions at leading pharmaceutical companies such as GlaxoSmithKline, Stiefel (a GSK Company), KV Pharmaceutical and Curatek Pharmaceuticals

Previous page 1 2 3 4 5 6 Next page